Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
John W Steinke & Jeff M Wilson. (2016) Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances. Journal of Asthma and Allergy 9, pages 37-43.
Read now
Read now
José Maria Guilemany, Isam Alobid & Joaquim Mullol. (2010) Controversies in the treatment of chronic rhinosinusitis. Expert Review of Respiratory Medicine 4:4, pages 463-477.
Read now
Read now
Isam Alobid, Sara Cardelús, Cèsar Picado & Joaquim Mullol. (2008) Antileukotrienes in rhinosinusitis and nasal polyposis. Expert Review of Clinical Immunology 4:3, pages 331-337.
Read now
Read now
Marzena E Krawiec & Sally E Wenzel. (2001) Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma. Expert Opinion on Pharmacotherapy 2:1, pages 47-65.
Read now
Read now
Yong Ju Jang. (2000) Arachidonic Acid Metabolites in Antrochoanal Polyp and Nasal Polyp Associated with Chronic Paranasal Sinusitis. Acta Oto-Laryngologica 120:4, pages 531-534.
Read now
Read now
Articles from other publishers (37)
Hyo-In Rhyou, Young-Hee Nam & Hae-Sim Park. (2022) Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease. Allergy, Asthma & Immunology Research 14:2, pages 153.
Crossref
Crossref
Esha Sehanobish, Mohammad Asad, Mali Barbi, Steven A. Porcelli & Elina Jerschow. (2021) Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease. Frontiers in Immunology 12.
Crossref
Crossref
Jong-Uk Lee, Jong Sook Park, Hun Soo Chang & Choon-Sik Park. (2019) Complementary Participation of Genetics and Epigenetics in Development of NSAID-exacerbated Respiratory Disease. Allergy, Asthma & Immunology Research 11:6, pages 779.
Crossref
Crossref
John W. Steinke, Anna R. Smith, Delaney J. Carpenter, James T. Patrie, Spencer C. Payne & Larry Borish. (2017) Lack of Efficacy of Symptoms and Medical History in Distinguishing the Degree of Eosinophilia in Nasal Polyps. The Journal of Allergy and Clinical Immunology: In Practice 5:6, pages 1582-1588.e3.
Crossref
Crossref
Katharine M. Woessner. (2017) Update on Aspirin-Exacerbated Respiratory Disease. Current Allergy and Asthma Reports 17:1.
Crossref
Crossref
Amber Dahlin & Scott T. Weiss. (2016) Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease. Immunology and Allergy Clinics of North America 36:4, pages 765-789.
Crossref
Crossref
John W. Steinke, Spencer C. Payne & Larry Borish. (2016) Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease. Immunology and Allergy Clinics of North America 36:4, pages 719-734.
Crossref
Crossref
María del Carmen Plaza-Serón, Pedro Ayuso, Natalia Pérez-Sánchez, Inmaculada Doña, Natalia Blanca-Lopez, Carlos Flores, Luisa Galindo, Ana Molina, James R. Perkins, Jose A. Cornejo-García, Jose A. Agúndez, Elena García-Martín, Paloma Campo, Gabriela Canto & Miguel Blanca. (2016) Copy number variation in ALOX5 and PTGER1 is associated with NSAIDs-induced urticaria and/or angioedema. Pharmacogenetics and Genomics 26:6, pages 280-287.
Crossref
Crossref
Ajnacska Rozsasi, Akos Heinemann & Tilman Keck. (2016)
Release of Cyclooxygenase-2 and Lipoxin A
4
from Blood Leukocytes in Aspirin-exacerbated Respiratory Disease
. Allergy & Rhinology 7:3, pages ar.2016.7.0172.
Crossref
Crossref
John W. Steinke & Larry Borish. (2015) Factors Driving the Aspirin Exacerbated Respiratory Disease Phenotype. American Journal of Rhinology & Allergy 29:1, pages 35-40.
Crossref
Crossref
Benjamin P. Hull & Joseph K. Han. 2015. Practical Medical and Surgical Management of Chronic Rhinosinusitis. Practical Medical and Surgical Management of Chronic Rhinosinusitis
73
110
.
Dirk Schäfer, Peter Dreßen, Stefan Brettner, Norbert-Folke Rath, Gerhard J Molderings, Katrin Jensen & Christina Ziemann. (2014) Prostaglandin D2-supplemented “functional eicosanoid testing and typing” assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study. Journal of Translational Medicine 12:1.
Crossref
Crossref
R. Pezato, M. Świerczyńska‐Krępa, E. Niżankowska‐Mogilnicka, L. Derycke, C. Bachert & C. A. Pérez‐Novo. (2012) Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis. Allergy 67:11, pages 1347-1356.
Crossref
Crossref
Hendrik Graefe, Christina Roebke, Dirk Schäfer & Jens Eduard Meyer. (2012) Aspirin Sensitivity and Chronic Rhinosinusitis with Polyps: A Fatal Combination. Journal of Allergy 2012, pages 1-10.
Crossref
Crossref
Isam Alobid & Joaquim Mullol. (2012) Role of Medical Therapy in the Management of Nasal Polyps. Current Allergy and Asthma Reports 12:2, pages 144-153.
Crossref
Crossref
John W. Steinke, Spencer C. Payne & Larry Borish. (2012) Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization. Journal of Allergy 2012, pages 1-9.
Crossref
Crossref
Spencer C. Payne, Larry Borish & John W. Steinke. (2011) Genetics and phenotyping in chronic sinusitis. Journal of Allergy and Clinical Immunology 128:4, pages 710-720.
Crossref
Crossref
Gül Karakaya & A. Fuat Kalyoncu. 2010. Nasal Polyposis. Nasal Polyposis
119
126
.
Andrzej Szczeklik, Ewa Ni?ankowska-Mogilnicka & Marek Sanak. 2009. Middleton's Allergy: Principles and Practice. Middleton's Allergy: Principles and Practice
1227
1243
.
Isam Alobid & Joaquim Mullol. (2008) Management of Rhinosinusitis Today. Clinical Pulmonary Medicine 15:6, pages 332-341.
Crossref
Crossref
Josep M. Guilemany, Jordi Roca-Ferrer & Joaquim Mullol. (2008) Cyclooxygenases and the pathogenesis of chronic rhinosinusitis and nasal polyposis. Current Allergy and Asthma Reports 8:3.
Crossref
Crossref
Hanns-Wolf Baenkler. (2008) Salicylate Intolerance. Deutsches Ärzteblatt international.
Crossref
Crossref
Claudia Jenneck, Uwe Juergens, Markus Buecheler & Natalija Novak. (2007) Pathogenesis, diagnosis, and treatment of aspirin intolerance. Annals of Allergy, Asthma & Immunology 99:1, pages 13-21.
Crossref
Crossref
Seung-Hyun Kim & Hae-Sim Park. (2006) Pathogenesis of nonsteroidal antiinflammatory drug-induced asthma. Current Opinion in Allergy & Clinical Immunology 6:1, pages 17-22.
Crossref
Crossref
Claudina Angela Pérez-Novo, Jean Baptiste Watelet, Cindy Claeys, Paul Van Cauwenberge & Claus Bachert. (2005) Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. Journal of Allergy and Clinical Immunology 115:6, pages 1189-1196.
Crossref
Crossref
Jens E. Meyer, Joachim Bartels, Tibor Görögh, Michael Sticherling, Claudia Rudack, Douglas A. Ross & Steffen Maune. (2018) The Role of RANTES in Nasal Polyposis. American Journal of Rhinology 19:1, pages 15-20.
Crossref
Crossref
Steven M. Parnes. (2003) The role of leukotriene inhibitors in patients with paranasal sinus disease. Current Opinion in Otolaryngology & Head and Neck Surgery 11:3, pages 184-191.
Crossref
Crossref
C. Picado, G. Bioque, J. Roca‐Ferrer, L. Pujols, J. Mullol, P. Benitez & O. Bulbena. (2003) Nuclear factor‐κB activity is down‐regulated in nasal polyps from aspirin‐sensitive asthmatics. Allergy 58:2, pages 122-126.
Crossref
Crossref
Pablo Arango, Larry Borish, Henry F. FriersonJrJr & Stilianos E. Kountakis. (2016) Cysteinyl Leukotrienes in Chronic Hyperplastic Rhinosinusitis. Otolaryngology–Head and Neck Surgery 127:6, pages 512-515.
Crossref
Crossref
César Picado. (2002) Aspirin intolerance and nasal polyposis. Current Allergy and Asthma Reports 2:6, pages 488-493.
Crossref
Crossref
Pablo Arango & Stilianos E. Kountakis. (2009) Presence of Cysteinyl Leukotrienes in Asthmatic Patients With Chronic Sinusitis. The Laryngoscope 112:7, pages 1190-1192.
Crossref
Crossref
Joaquim Mullol, Joan C. Fern?ndez-Morata, Jordi Roca-Ferrer, Laura Pujols, Antoni Xaubet, Pedro Benitez & Cesar Picado. (2002) Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. Journal of Allergy and Clinical Immunology 109:5, pages 824-830.
Crossref
Crossref
Stephen M. Parnes. (2002) The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis. Current Allergy and Asthma Reports 2:3, pages 239-244.
Crossref
Crossref
Nancy E. Ziroli, Hanjo Na, James M. Chow, James A. Stankiewicz, Max Samter & M. Rita I. Young. (2016) Aspirin‐Sensitive versus Non‐Aspirin‐Sensitive Nasal Polyp Patients: Analysis of Leukotrienes/fas and Fas‐Ligand Expression. Otolaryngology–Head and Neck Surgery 126:2, pages 141-146.
Crossref
Crossref
G. Çelik, S. Bavbek, Z. Misirligil & M. Melli. (2008)
Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E
2
on this release from peripheral blood leucocytes in aspirin‐induced asthmatic patients
. Clinical & Experimental Allergy 31:10, pages 1615-1622.
Crossref
Crossref
Paraya Assanasen & Robert M. Naclerio. (2001) Medical and surgical management of nasal polyps. Current Opinion in Otolaryngology & Head and Neck Surgery 9:1, pages 27-36.
Crossref
Crossref
Bettina Wedi & Alexander Kapp. (2001) Pathophysiological Role of Leukotrienes in Dermatological Diseases. BioDrugs 15:11, pages 729-743.
Crossref
Crossref